Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam besylate with opioids for painless flexible bronchoscopy
ChiCTR2300071207Phase 4Not yet recruiting
- Sponsor
- Second Affiliated Hospital of Zunyi Medical University
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in None (4 arms), sponsored by Second Affiliated Hospital of Zunyi Medical University. Primary endpoints: Sedation success rate and Number of drug refills. Planned start Apr 2023; status: not yet recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2300071207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300071207.